[HTML][HTML] Vincristine-induced peripheral neuropathy in childhood acute lymphoblastic leukemia: genetic variation as a potential risk factor

QY Yang, YH Hu, HL Guo, Y Xia, Y Zhang… - Frontiers in …, 2021 - frontiersin.org
Vincristine (VCR) is the first-line chemotherapeutic medication often co-administered with
other drugs to treat childhood acute lymphoblastic leukemia. Dose-dependent neurotoxicity …

[HTML][HTML] Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor

QY Yang, YH Hu, HL Guo, Y Xia, Y Zhang… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Vincristine (VCR) is the first-line chemotherapeutic medication often co-administered with
other drugs to treat childhood acute lymphoblastic leukemia. Dose-dependent neurotoxicity …

Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.

QY Yang, YH Hu, HL Guo, Y Xia, Y Zhang… - Frontiers in …, 2021 - europepmc.org
Vincristine (VCR) is the first-line chemotherapeutic medication often co-administered with
other drugs to treat childhood acute lymphoblastic leukemia. Dose-dependent neurotoxicity …

[引用][C] Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor

QY Yang, YH Hu, HL Guo, Y Xia, Y Zhang… - Frontiers in …, 2021 - jglobal.jst.go.jp
Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia:
Genetic Variation as a Potential Risk Factor | Article Information | J-GLOBAL Art J-GLOBAL …

Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor

QY Yang, YH Hu, HL Guo, Y Xia… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Vincristine (VCR) is the first-line chemotherapeutic medication often co-administered with
other drugs to treat childhood acute lymphoblastic leukemia. Dose-dependent neurotoxicity …